Why the study?
Patient-reported outcome metrics quantify important outcomes, but no validated disease-specific metric existed for adults with congenital heart disease.
Does a novel ACHD-specific Patient-Reported Outcome (PRO) metric demonstrate validity and reliability in adults with congenital heart disease?
Does a novel ACHD-specific Patient-Reported Outcome (PRO) metric demonstrate validity and reliability in adults with congenital heart disease?
A novel ACHD-specific patient-reported outcome metric demonstrates initial validity and reliability, providing a potential new tool for quantifying patient experience in clinical trials and practice.
Answers are grounded in this paper and cite their sources.
ACHD PRO reliability supports its testing in trials; leaves open clinical adoption without further validation.
Background Patient-reported outcome metrics (PROs) quantify important outcomes in clinical trials and can be sensitive measures of patient experience in clinical practice. Currently, there is no validated disease-specific PRO for adults with congenital heart disease (ACHD). Methods and Results We conducted a preliminary psychometric validation of a novel ACHD PRO. ACHD patients were recruited prospectively from 2 institutions and completed a series of questionnaires, a physician health assessment, and a 6-minute walk test. Participants returned to complete the same questionnaires and assessment 3 months±2 weeks later. We tested the internal consistency and test-retest reliability by comparing responses among clinically stable patients at the 2 study visits. We assessed convergent and divergent validity by comparison of ACHD PRO responses to existing validated questionnaires. We assessed responsiveness by comparison with patient-reported clinical change. One hundred three patients completed 1 study visit and 81 completed both. The ACHD PRO demonstrated good internal consistency in each of its 5 domains (Cronbach's α: 0.87; 0.74; 0.74; 0.90; and 0.89, respectively) and in the overall summary score (0.92). Test-retest reliability was good with an intraclass correlation ≥0.73 for all domains and 0.78 for the Summary Score. The ACHD PRO accurately assessed domain concepts based on comparison with validated standards. Preliminary estimates of responsiveness suggest sensitivity to clinical status. Conclusions These studies provide initial support for the validity and reliability of the ACHD PRO. Further studies are needed to assess its sensitivity to changes in clinical status.
No takes yet. Share an insight, caveat, or question.
Cedars et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: